Jeffrey M. Switchenko

5.2k total citations
257 papers, 3.0k citations indexed

About

Jeffrey M. Switchenko is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jeffrey M. Switchenko has authored 257 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Oncology, 74 papers in Pulmonary and Respiratory Medicine and 47 papers in Surgery. Recurrent topics in Jeffrey M. Switchenko's work include Lymphoma Diagnosis and Treatment (31 papers), Head and Neck Cancer Studies (30 papers) and Pancreatic and Hepatic Oncology Research (19 papers). Jeffrey M. Switchenko is often cited by papers focused on Lymphoma Diagnosis and Treatment (31 papers), Head and Neck Cancer Studies (30 papers) and Pancreatic and Hepatic Oncology Research (19 papers). Jeffrey M. Switchenko collaborates with scholars based in United States, India and Canada. Jeffrey M. Switchenko's co-authors include Richard J. Cassidy, Mohammad K. Khan, Kirtesh R. Patel, Walter J. Curran, Theresa Gillespie, Christopher R. Flowers, Anees Dhabaan, Justin Roper, Jonathan J. Beitler and Kevin C. Ward and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Jeffrey M. Switchenko

237 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey M. Switchenko United States	29	1.3k	817	529	413	403	257	3.0k
Erqi L. Pollom United States	27	924 0.7×	1.0k 1.2×	612 1.2×	537 1.3×	566 1.4×	195	2.8k
Elizabeth A. Handorf United States	34	1.4k 1.1×	1.1k 1.3×	869 1.6×	400 1.0×	201 0.5×	179	3.4k
Surbhi Grover United States	34	1.4k 1.1×	947 1.2×	699 1.3×	795 1.9×	896 2.2×	216	3.6k
Harald Anderson Sweden	34	1.3k 1.0×	956 1.2×	639 1.2×	381 0.9×	430 1.1×	79	4.1k
R. Pearcey Canada	25	900 0.7×	689 0.8×	724 1.4×	461 1.1×	421 1.0×	73	3.0k
Matthew Koshy United States	36	1.2k 0.9×	1.7k 2.1×	781 1.5×	324 0.8×	658 1.6×	125	4.3k
Mathias Bressel Australia	35	1.4k 1.1×	1.7k 2.1×	789 1.5×	209 0.5×	1.0k 2.5×	184	3.8k
Shalom Kalnicki United States	32	1.2k 0.9×	1.1k 1.3×	1.0k 2.0×	426 1.0×	878 2.2×	186	3.7k
B. Ashleigh Guadagnolo United States	38	2.2k 1.7×	1.9k 2.3×	664 1.3×	372 0.9×	259 0.6×	143	4.2k
G.R. Kerr United Kingdom	31	1.1k 0.9×	1.1k 1.4×	1.2k 2.2×	222 0.5×	346 0.9×	97	3.2k

Countries citing papers authored by Jeffrey M. Switchenko

Since Specialization

Citations

This map shows the geographic impact of Jeffrey M. Switchenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Switchenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Switchenko more than expected).

Fields of papers citing papers by Jeffrey M. Switchenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Switchenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Switchenko. The network helps show where Jeffrey M. Switchenko may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Switchenko

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Switchenko. A scholar is included among the top collaborators of Jeffrey M. Switchenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Switchenko. Jeffrey M. Switchenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alese, Olatunji B., Natalie K. Horvat, Emily R. Greene, et al.. (2025). XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial. OncoImmunology. 14(1). 2475620–2475620. 5 indexed citations

Schoettler, Michelle Long, Shanmuganathan Chandrakasan, Suhag Parikh, et al.. (2024). D‐dimer and sinusoidal obstructive syndrome‐novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. American Journal of Hematology. 99(3). 370–379. 7 indexed citations

Steuer, Conor, Jennifer W. Carlisle, Ticiana Leal, et al.. (2024). P1.12A.09 A Phase 1b Study of the MER Tyrosine Kinase Inhibitor, MRX-2843, in Combination with Osimertinib in Advanced EGFR Mutant Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 19(10). S196–S196.

Switchenko, Jeffrey M., Madhusmita Behera, Mehmet Asım Bilen, et al.. (2023). Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast. The Oncologist. 28(12). 1055–1063.

Switchenko, Jeffrey M., et al.. (2023). Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study. Clinical Lymphoma Myeloma & Leukemia. 23(9). 667–673. 5 indexed citations

Postlewait, Lauren M., Theresa Gillespie, Cletus A. Arciero, et al.. (2023). Outcomes of the same‐day discharge following mastectomy before, during and after COVID‐19 pandemic. Journal of Surgical Oncology. 127(5). 761–767. 5 indexed citations

Hüls, Anke, Grace M. Christensen, Zhenjiang Li, et al.. (2023). Environmental, social and behavioral risk factors in association with spatial clustering of childhood cancer incidence. Spatial and Spatio-temporal Epidemiology. 45. 100582–100582. 3 indexed citations

Allaw, Mohammed, Jeffrey M. Switchenko, Lana Khalil, et al.. (2022). Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. Oncology. 100(3). 131–139. 6 indexed citations

Kokabi, Nima, Mohammad Elsayed, Jeffrey M. Switchenko, et al.. (2022). Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial. Journal of Vascular and Interventional Radiology. 33(12). 1578–1587.e5. 11 indexed citations

10.

Marks, Jennifer A., Jeffrey M. Switchenko, Conor Steuer, et al.. (2021). Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma. JCO Oncology Practice. 17(3). e313–e322. 17 indexed citations

11.

Allen, Pamela B., et al.. (2021). Risk Factors for Progression from Early to Advanced Stage Mycosis Fungoides: A Single Center Retrospective Analysis at the Winship Cancer Institute of Emory University. Blood. 138(Supplement 1). 1378–1378. 4 indexed citations

12.

Gamboa, Adriana C., Manali Rupji, Jeffrey M. Switchenko, et al.. (2020). Optimal timing and treatment strategy for pancreatic cancer. Journal of Surgical Oncology. 122(3). 457–468. 28 indexed citations

13.

Lee, Rachel, et al.. (2019). Is Routine Recurrence Score Testing in Patients Older than 70 Years of Age Warranted? An Evaluation of the National Cancer Database After TAILORx. Annals of Surgical Oncology. 26(10). 3152–3158. 2 indexed citations

14.

Gamboa, Adriana C., Cecilia G. Ethun, Jeffrey M. Switchenko, et al.. (2019). Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?. Journal of the American College of Surgeons. 229(5). 449–457. 11 indexed citations

15.

Buchwald, Zachary S., Jaymin Jhaveri, Eduard Schreibmann, et al.. (2019). Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases. Practical Radiation Oncology. 10(1). 36–43. 16 indexed citations

16.

Rudra, Soumon, Jeffrey M. Switchenko, Donna Mister, et al.. (2018). CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy. International Journal of Breast Cancer. 2018. 1–9. 19 indexed citations

17.

Davis, Christine, et al.. (2016). Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving Trastuzumab. Annals of Pharmacotherapy. 50(9). 712–717. 11 indexed citations

18.

Patel, Kirtesh R., Jeffrey M. Switchenko, Kelly R. Magliocca, et al.. (2016). Adjuvant Radiation Therapy Improved Local Control for Primary Mucosal Melanoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 96(2). E384–E385. 1 indexed citations

19.

Chowdhary, Mudit, Kirtesh R. Patel, Jeffrey M. Switchenko, et al.. (2016). Increased Risk of Radiation Necrosis Following BRAF inhibitor therapy and Stereotactic Radiosurgery (SRS). International Journal of Radiation Oncology*Biology*Physics. 96(2). S59–S59.

20.

Oliver, Daniel, Kirtesh R. Patel, Jeffrey M. Switchenko, et al.. (2015). Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma Research. 26(1). 35–41. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact